-Parties: The applicants included Vertex Pharmaceuticals (Canada) Inc. et al. The respondent was JAMP Pharma Corp.

-Subject Matter: This is an action before the Federal Court under the Patented Medicines (Notice of Compliance) Regulations, filed on April 23, 2026. The proceeding involves pharmaceutical patent-related claims and has been designated as a specially managed proceeding, with a scheduled evidentiary hearing in Toronto. The case is ongoing.

-Date: The hearing was set on May 27, 2026.

-Venue: This was a federal case before the Federal Court.

-Amount: No financial award was specified.